First Quadrant’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-46,442
| Closed | -$6.02M | – | 273 |
|
|
2021
Q4 | $6.02M | Hold |
46,442
| – | – | 0.65% | 27 |
|
|
2021
Q3 | $5.26M | Hold |
46,442
| – | – | 0.61% | 23 |
|
|
2021
Q2 | $4.81M | Sell |
46,442
-1,914
| -4% | -$180K | 0.55% | 29 |
|
|
2021
Q1 | $4.04M | Buy |
48,356
+41
| +0.1% | +$3.47K | 0.43% | 36 |
|
|
2020
Q4 | $4.41M | Sell |
48,315
-1,224
| -2% | -$102K | 0.44% | 32 |
|
|
2020
Q3 | $3.95M | Sell |
49,539
-3,492
| -7% | -$272K | 0.5% | 35 |
|
|
2020
Q2 | $3.67M | Sell |
53,031
-9,687
| -15% | -$688K | 0.49% | 36 |
|
|
2020
Q1 | $3.94M | Buy |
62,718
+16,047
| +34% | +$1.16M | 0.57% | 38 |
|
|
2019
Q4 | $3.63M | Sell |
46,671
-31,848
| -41% | -$2.49M | 0.3% | 76 |
|
|
2019
Q3 | $5.76M | Sell |
78,519
-68,928
| -47% | -$4.84M | 0.54% | 37 |
|
|
2019
Q2 | $9.08M | Buy |
147,447
+28,347
| +24% | +$1.71M | 0.63% | 24 |
|
|
2019
Q1 | $7.6M | Sell |
119,100
-1,836
| -2% | -$105K | 0.58% | 33 |
|
|
2018
Q4 | $6.17M | Hold |
120,936
| – | – | 0.5% | 37 |
|
|
2018
Q3 | $7.02M | Sell |
120,936
-165,330
| -58% | -$8.09M | 0.16% | 178 |
|
|
2018
Q2 | $13.9M | Hold |
286,266
| – | – | 0.26% | 125 |
|
|
2018
Q1 | $13.3M | Hold |
286,266
| – | – | 0.25% | 146 |
|
|
2017
Q4 | $10.8M | Buy |
286,266
+36,498
| +15% | +$1.34M | 0.2% | 158 |
|
|
2017
Q3 | $9.1M | Buy |
249,768
+58,584
| +31% | +$2.23M | 0.18% | 182 |
|
|
2017
Q2 | $7.54M | Buy |
191,184
+1,284
| +0.7% | +$46.9K | 0.15% | 195 |
|
|
2017
Q1 | $5.96M | Hold |
189,900
| – | – | 0.12% | 225 |
|
|
2016
Q4 | $5.93M | Hold |
189,900
| – | – | 0.12% | 224 |
|
|
2016
Q3 | $7.63M | Hold |
189,900
| – | – | 0.16% | 187 |
|
|
2016
Q2 | $6.31M | Buy |
189,900
+2,100
| +1% | +$71.8K | 0.14% | 184 |
|
|
2016
Q1 | $5.52M | Sell |
187,800
-1,800
| -0.9% | -$49.7K | 0.12% | 194 |
|
|
2015
Q4 | $4.99M | Sell |
189,600
-1,584
| -0.8% | -$41.1K | 0.11% | 210 |
|
|
2015
Q3 | $4.53M | Sell |
191,184
-13,200
| -6% | -$319K | 0.1% | 218 |
|
|
2015
Q2 | $4.85M | Sell |
204,384
-38,400
| -16% | -$867K | 0.1% | 204 |
|
|
2015
Q1 | $5.76M | Sell |
242,784
-934,200
| -79% | -$21M | 0.12% | 184 |
|
|
2014
Q4 | $25M | Sell |
1,176,984
-630,600
| -35% | -$12.7M | 0.53% | 64 |
|
|
2014
Q3 | $30.8M | Buy |
1,807,584
+1,690,200
| +1,440% | +$26.7M | 0.69% | 38 |
|
|
2014
Q2 | $1.68M | Hold |
117,384
| – | – | 0.04% | 321 |
|
|
2014
Q1 | $1.45M | Hold |
117,384
| – | – | 0.03% | 331 |
|
|
2013
Q4 | $1.29M | Hold |
117,384
| – | – | 0.03% | 358 |
|
|
2013
Q3 | $1.36M | Sell |
117,384
-150,600
| -56% | -$1.76M | 0.03% | 333 |
|
|
2013
Q2 | $3M | Buy |
+267,984
| New | +$3.17M | 0.08% | 248 |
|
Other funds holding EW
First Quadrant's EW Position: Q1 2022 in Review
First Quadrant sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 46,442 shares — an estimated $6.02M sold.
First Quadrant first reported a position in EW in Q2 2013 and held it in 35 quarters. The position peaked at $30.8M in Q3 2014. 1,315 funds tracked by Wall St. Rank hold EW as of Q1 2022.
- First Quadrant reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
- First Quadrant sold 46,442 Edwards Lifesciences shares in Q1 2022, an estimated $6.02M.
- First Quadrant first reported a position in Edwards Lifesciences in Q2 2013 and held it in 35 quarters.
- First Quadrant's Edwards Lifesciences position peaked at $30.8M in Q3 2014.
- 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.
Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.